Localized Delivery of Interferon-β by Lactobacillus Exacerbates Experimental Colitis
2011

Lactobacillus Expressing Interferon-β Exacerbates Colitis

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Adelle P. McFarland, Ram Savan, Wagage Sagie, Augustina Addison, Karthika Ramakrishnan, Megan Karwan, Tri Duong, Howard A. Young

Primary Institution: National Cancer Institute, Frederick, Maryland, USA

Hypothesis

Does localized delivery of interferon-β via Lactobacillus exacerbate experimental colitis?

Conclusion

The study found that Lactobacillus secreting interferon-β worsens colitis symptoms in mice.

Supporting Evidence

  • IFNAR1−/− mice showed increased sensitivity to DSS-induced colitis.
  • Colitic mice pretreated with La-IFN-β had increased levels of proinflammatory cytokines.
  • Loss of IFNAR1 expression on dendritic cells correlated with exacerbation of colitis.

Takeaway

Researchers used a special bacteria to deliver a protein that usually helps with inflammation, but instead, it made the inflammation worse in mice.

Methodology

Mice were pretreated with Lactobacillus expressing interferon-β before being induced with colitis using DSS.

Potential Biases

Potential bias in the interpretation of results due to the specific model used.

Limitations

The study was conducted in a murine model, which may not fully replicate human conditions.

Participant Demographics

Mice used were A/J and C57BL/6 strains, aged 8-12 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016967

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication